The US Food & Drug Administration (USFDA) has classified the Alembic Pharmaceuticals’ General Oral Solid Formulation Facility located at Panelav as Voluntary Action Indicated (VAI). Inspection at the said Facility was conducted by USFDA from March 09, 2020 to March 13, 2020.
VAI means USFDA accepted the Company’s response to its observations.
Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.